Ried M, Hofmann H-S
Abteilung für Thoraxchirurgie, Universitätsklinikum Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Deutschland.
Chirurg. 2013 Jun;84(6):492-6. doi: 10.1007/s00104-012-2433-4.
Trimodality treatment including induction and/or adjuvant chemotherapy, surgical resection and in some cases radiotherapy offers a curative intention in selected patients with pleural malignancies (malignant pleural mesothelioma, thymoma with pleural spread). Nevertheless, locoregional tumor recurrence mainly limits the outcome and the quality of life. A few years ago an additional intraoperative chemotherapy perfusion was developed in order to improve local tumor control and prognosis after surgical resection in a multimodality treatment setting. Cytoreductive surgery with the purpose of a macroscopic complete resection could be achieved by radical pleurectomy or extrapleural pneumonectomy. The concept, techniques and perioperative management of this additional treatment option are presented along with a detailed review of the recent literature.
三联疗法包括诱导化疗和/或辅助化疗、手术切除,在某些情况下还包括放疗,可为部分胸膜恶性肿瘤(恶性胸膜间皮瘤、伴有胸膜播散的胸腺瘤)患者提供治愈的可能。然而,局部区域肿瘤复发仍是影响治疗效果和生活质量的主要因素。几年前,人们开发了一种术中化疗灌注技术,旨在改善多模式治疗中手术切除后的局部肿瘤控制和预后。通过根治性胸膜切除术或胸膜外全肺切除术可实现以肉眼完全切除为目的的肿瘤细胞减灭术。本文介绍了这种额外治疗方案的概念、技术和围手术期管理,并对近期文献进行了详细综述。